QIAGEN powered by
Progranulin: A novel and sensitive biomarker with a key role in immune response in sepsis

QIAGEN Digital Insights Wednesday, September 11, 2019

QIAGEN collaborates with a team from the University of Munich by applying bioinformatics software tools OmicSoft ArrayStudio and Ingenuity Pathway Analysis (IPA) to discover progranulin as a novel and sensitive biomarker for sepsis.